Top compounds associated with response to MT-ND4L


Feature Type Standardized
Nominal ANOVA
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.091 0.02
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.03
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.03
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.13 0.03
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.03
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.091 0.03
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.03
mRNA Axitinib CTRPv2 pan-cancer AAC -0.085 0.03
mRNA avicin D CTRPv2 pan-cancer AAC -0.14 0.03
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.04
Download CSV